Date of this Version
This brief summarizes a new systematic review of economic evaluations of treatments for substance use disorders. The review reveals strong evidence that methadone maintenance therapy is an economically advantageous form of treatment; the economic evidence for buprenorphine and naltrexone treatments is more limited.
This work is licensed under a Creative Commons Attribution-No Derivative Works 4.0 License.
pharmaceuticals, cost effectiveness analysis, health insurance
View On LDI Website
Date Posted: 09 December 2016